Intravenous fish oil in hospitalized adult patients: Reviewing the reviews

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 16, Issue 2, 2013, Pages 119-123

  Calder, Philip C ^a   Deckelbaum, Richard J ^b  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b NewYork Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; FISH OIL; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID;

CANCER SURGERY; CRITICALLY ILL PATIENT; HOSPITAL PATIENT; HOSPITALIZATION; INTENSIVE CARE; LENGTH OF STAY; META ANALYSIS (TOPIC); PARENTERAL NUTRITION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW;

ADMINISTRATION, INTRAVENOUS; ADULT; FATTY ACIDS, OMEGA-3; FATTY ACIDS, UNSATURATED; FISH OILS; HOSPITALIZATION; HUMANS; META-ANALYSIS AS TOPIC;

EID: 84873407440     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0b013e32835dbde9     Document Type: Review

References (24)

1. Calder PC. Mechanisms of action of (n-3) fatty acids. J Nutr 2012; 142:592S-599S.
2. Calder PC. Fatty acids and inflammation: the cutting edge between food and pharma. Eur J Pharmacol 2011; 668:S50-S58.
3. Yaqoob P, Pala HS, Cortina-Borja M, et al. Encapsulated fish oil enriched in a-tocopherol alters plasma phospholipid and mononuclear cell fatty acid compositions but not mononuclear cell functions. Eur J Clin Invest 2000; 30:260-274.
4. Rees D, Miles EA, Banerjee T, et al. Dose-related effects of eicosapentaenoic acid on innate immune function in healthy humans: a comparison of young and older men. Am J Clin Nutr 2005; 83:331-342.
5. Faber J, Berkhout M, Vos AP, et al. Supplementation with a fish oil-enriched, high-protein medical food leads to rapid incorporation of EPA into white blood cells and modulates immune responses within one week in healthy men and women. J Nutr 2011; 141:964-970.
6. Wada M, DeLong CJ, Hong YH, et al. Enzymes and receptors of prostaglandin pathways with arachidonic acid-derived versus eicosapentaenoic acidderived substrates and products. J Biol Chem 2007; 282:22254-22266.
7. Serhan CN, Hong S, Gronert K, Colgan SP, et al. Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter pro-inflammation signals. J Exp Med 2002; 196:1025-1037.
8. Serhan CN, Chiang N, van Dyke TE. Resolving inflammation: dual antiinflammatory and pro-resolution lipid mediators. Nat Rev Immunol 2008; 8:349-361.
9. Zhang MJ, Spite M. Resolvins: anti-inflammatory and proresolving mediators derived from omega-3 polyunsaturated fatty acids. Annu Rev Nutr 2012; 32:203-227.
10. Yaqoob P. The nutritional significance of lipid rafts. Annu Rev Nutr 2009; 29:257-282.
11. Yaqoob P, Shaikh SR. The nutritional and clinical significance of lipid rafts. Curr Opin Clin Nutr Metab Care 2010; 13:156-166.
12. Lee JY, Sohn KH, Rhee SH, et al. Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Tolllike receptor 4. J Biol Chem 2001; 276:16683-16689.
13. Weatherill AR, Lee JY, Zhao L, et al. Saturated and polyunsaturated fatty acids reciprocally modulate dendritic cell functions mediated through TLR4. J Immunol 2005; 174:5390-5397.
14. Oh DY, Talukdar S, Bae EJ, et al. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 2010; 142:687-698.
15. Calder PC. Rationale for using new lipid emulsions in parenteral nutrition and a review of the trials performed in adults. Proc Nutr Soc 2009; 68:252-260.
16. Calder PC. Rationale and use of n-3 fatty acids in artificial nutrition. Proc Nutr Soc 2010; 69:565-573.
17. Wei C, Hua J, Bin C, Klassen K. Impact of lipid emulsion containing fish oil on outcomes in surgical patients: systematic review of randomized controlled trials from Europe and Asia. Nutrition 2010; 26:474-481.
18. Chen B, Zhou Y, Yang P, et al. Safety and efficacy of fish oil-enriched parenteral nutrition regimen on postoperative patients undergoing major abdominal surgery: a meta-analysis of randomized controlled trials. JPEN J Parenter Enteral Nutr 2010; 34:387-394.
19. Vander Meij BS, van Bokhorst-de Vander Schueren MAE, Langius JAE, et al. N-3 PUFAs in cancer, surgery, and critical care: a systematic review on clinical effects, incorporation, and washout of oral or enteral compared with parenteral supplementation. Am J Clin Nutr 2011; 94:1248-1265.
20. Pradelli L, Mayer K, Muscaritoli M, Heller AR. N-3 fatty acid-enriched parenteral nutrition regimens in elective surgical and ICU patients: a metaanalysis. Crit Care 2012; 16:R184.
21. Palmer AJ, Ho CKM, Ajibola O, Avenell A. The role of v-3 fatty acid supplemented parenteral nutrition in critical illness in adults: a systematic review and meta-analysis. Crit Care Med 2013; 41: 300-309.
22. Grecu I, Mirea L, Grintescu I. Parenteral fish oil supplementation in patients with abdominal sepsis. Clin Nutr 2003; 22:S23.
23. Wang X, Li W, Li N, Li J. Omega-3 fatty acids-supplemented parenteral nutrition decreases hyperinflammatory response and attenuates systemic disease sequelae in severe acute pancreatitis: a randomized and controlled study. JPEN J Parenter Enteral Nutr 2008; 32:236-241.
24. Barbosa VM, Miles EA, Calhau C, et al. Effects of a fish oil containing lipid emulsion on plasma phospholipid fatty acids, inflammatory markers, and clinical outcomes in septic patients: a randomized, controlled clinical trial. Crit Care 2010; 14:R5.